Aspire Pharma selects Slimstock to support its next phase of growth

Aspire Pharma has selected Slimstock’s solution to strengthen its inventory planning capabilities and create a more scalable foundation for continued growth.

Aspire Pharma is a UK-based pharmaceutical company focused on developing and supplying niche generic medicines and innovative healthcare products. Since its foundation in 2009, the company has remained focused on improving patients’ lives by developing and supplying medicines that create meaningful value for patients, healthcare professionals and healthcare systems worldwide.

Following a period of significant expansion, Aspire identified an opportunity to introduce a more dynamic and forward-looking approach to inventory management. Increasing volatility within the UK pharmaceutical market has made it increasingly important to balance high product availability with efficient working capital management and reduced exposure to excess stock.

Through its partnership with Slimstock, Aspire will gain greater visibility of future inventory requirements and potential supply chain risks. Slim4 will support more informed, data-driven decisions while reducing reliance on manual processes and allowing the planning team to spend more time on strategic, value-adding activities.

The platform will complement Aspire’s existing technology landscape, enabling the business to enhance its planning capabilities without creating unnecessary disruption to established systems and processes.

Matthew Toms, Operations Director at Aspire Pharma, commented:

“The pharmaceutical market is becoming increasingly dynamic, which means our approach to inventory planning needs to continue evolving. We wanted a solution that could complement our existing systems while giving us a more responsive and transparent way to manage inventory. Slim4 will help us right-size stock, maintain strong product availability and give our team clearer visibility of the areas requiring attention.”

The partnership represents an important step in Aspire’s continued development, creating a scalable planning foundation to support future growth and closer alignment across the business.

Will Severn, UK Sales Director at Slimstock, added:

“Aspire has achieved impressive growth and operates in a complex market where demand patterns and supply conditions can change quickly.Slim4 will provide the visibility and control needed to respond more effectively, maintain product availability and optimise inventory investment. We are delighted to be working with the Aspire team as they enter the next stage of their supply chain journey.”

Preparations are now underway, with the project targeting go-live in early 2027.